Hoxton Ventures

"Traditional industries have been left behind by the digital revolution due to the complexity of their operational challenges. Cogna’s mission is to empower these sectors with precision software technology that addresses every unique company pain point on its own terms, enabling immediate productivity gains. This funding allows us to bring our technology to more industries and help organisations reduce bottlenecks and free their expert teams from arduous manual tasks, unlocking their vast untapped potential."

"The Fundamental AI Research (FAIR) team is looking forward to collaborating with CuspAI in their use of AI, including our OpenDAC work, to accelerate the discovery of novel DAC sorbent materials. The world needs fast progress on affordable carbon capture, and we believe that CuspAI’s team is in an excellent position to apply AI-based materials discovery to this pressing problem."

"There is no better place in Europe to build an AI business"

"Cadent is dedicated to leading the gas industry in the UK and globally in managing gas escapes more effectively. Our focus is on ensuring safety, reliability, and efficiency for the ultimate benefit of our customers. Cogna’s rapid delivery of innovative software solutions, are proving to be key to this approach. Their technology will enable us to respond more quickly and effectively, marking a pivotal shift in our operations. We see this approach as the future of the industry, where speed, efficiency and performance for customers are paramount."

"On average, 40% of a data team’s time is spent answering questions from across their business. A lot of these questions are easy to answer for the data team but take them away from the deeper, more strategic analysis that can be transformative to their business. With Fluent’s natural language interface, we’re helping team members self-serve on their data questions."

"Diagnosing and treating ADHD can be a long and costly process, and living with the symptoms can be extremely challenging. We want to help our members make significant improvements to their quality of life by giving them the tools to better understand themselves, and implement coping strategies that actually work."

"The typical pharmacy experience has long been in need of an upgrade, and most pharmacists, despite being well trained and highly knowledgeable, are so bogged down by manual, repetitive tasks that they only have time to provide a basic, transactional service. Our mission is to provide a personalised pharmacy service for people who are on lots of medication that makes accessing the drugs and support they need a whole lot easier for them."

"My story – and Juno’s raison d’etre – will sound all-too-familiar to many. When I started my career as a Growth Manager for startups, long hours and ‘hustle culture’ left me feeling burnt out. The loss of a family member finally broke me and the thing I needed the most at that time was genuine wellbeing support in place of the alcohol-fuelled socials and awkward team yoga I was offered by HR. But I should have known not to expect too much from superficial ‘perks’ systems that fail to consider peoples’ actual needs."

"Replan embeds cutting-edge AI modelling and optimisation capabilities within a modern, intuitive user interface to shake up the status quo and revolutionise supply chain planning. The software can streamline even the most complex production plans, helping manufacturers to improve operational efficiency,and build more agile and resilient supply chains."

"In the world of quantum technologies, where data acquisition is expensive and the parameter space is large, it is a massive challenge to develop software to characterise and control qubits at scale,"

"We knew we could simplify the ADHD care process and reach millions of underserved people living with ADHD"

"The office concept has changed drastically as companies look to strike a balance between HQ and people’s homes. The real estate industry needs to innovate and redefine the role of office space for the future. We congratulate Kitt on its vision, which is at the centre of the largest shift in commercial real estate we’ve seen in recent years."

"One reason for the recent decline in the uptake of rapid Covid-19 tests is the sampling technique – it’s currently very uncomfortable and difficult for people to use. We need to take the pain out of mass testing if we’re to return to normal to minimise the disruption caused by future COVID-19 outbreaks, whether in offices, schools or hospitality venues. That’s why we’ve built supportive bio security technology that sits alongside the test, allowing users to generate their own unique QR codes to facilitate safe venue entry."

"Today, we’ve developed the world’s first Engineering-Grade AR solution helping construction teams identify errors in real-time, but really that’s just the start of our journey. The next phase is Assisted Reality, where our spatial computing technology will have the intelligence to automatically detect and report issues in the field. And ultimately, the goal is builders building from holograms. Our vision of developing world changing products aligns with Octopus Ventures’ mission of investing in companies that are powering the next industrial revolution. We look forward to building history."

"At Fy!, we're passionate about building a new way to shop for all the products people care about. We're thrilled to add Hoxton Ventures to the team and chose them due to their strong track record in supporting UK startups scale globally. We will be using this latest investment to continue to grow internationally – the US sales already make up over a third of Fy!'s revenue – by expanding our assortment there and launching Fy! in a number of large European markets."

"Our sole focus at Peptone is to embrace experimental failure and, in fact, acknowledge it as an absolutely vital stage in the process of getting the design of protein-based medicines right. Great science is always born out of failure. The reality is that drug discovery in Big Pharma sees only a small fraction of protein based drugs pass the preclinical stages due to their complexity. Pharma, just like any industry, is subject to the ‘power law’. A small number of innovative drugs generate disproportional benefits to patients and outsized capital returns. We are working on shifting this failure-to-success ratio in a meticulously predictable and repeatable way using the best computational methods and scalable data science. Only last week one of our clients produced a monoclonal antibody for which our platform suggested seven radical mutations. The said therapeutic protein got vastly improved. The probability of a human researcher being able to engineer this type of change is equal to 1/1,280,000,000. In layman terms you are four times more likely to win the Powerball lottery than to spontaneously find the solution our platform has identified in less than ten days. The business of protein therapeutics is a huge industry and as we grow and further develop our supercomputing capacity we can help make significant progress in the time to market for much sought-after protein-based treatments."

"This is one of the most highly-anticipated stages of our business and a really important step. We’ve spent time talking to our customers and industry specialists, and seen huge enthusiasm for DK-One’s potential. Now up and running, this will be the first time we can use a pre-production machine to demonstrate the DK-One’s commercial and nutritional benefits in the real world and thus demonstrate our vision for the future of food. I am proud of our amazing team for the work they’ve done to get this far this quickly, despite the challenges of the pandemic. We are all really excited to begin fulfilling our customer’s expectations."

"Our growth numbers speak for themselves. Subscriptions grew 800% in 2019 and will be even higher in 2020,"

"I am delighted to announce our Series A as yet another sign of the momentum we’re building at Skin Analytics"

"Unfortunately, global pandemics don’t slow down the antagonists, the battle of defending against and responding to malicious activity across the digital estate remains constant. To add to the challenge, a new working-from-home-norm has been introduced which increases IT service delivery and business continuity pressures."

"We are delighted to be working with Octopus Ventures to continue our growth path. The endorsement of one of Europe’s leading VCs provides hugely valued market validation to the work Vitesse has done and continues to do. Their crucial support will help us to keep drivingcompany expansion and continue to transform the payments market."

"The foundation of Kheiron’s approach to rigorous development and testing is to ensure reliably improved patient outcomes and safety by helping doctors in their daily practice,"

"At Karakuri, we are dedicated to providing smart new ways to create and prepare fresh personalised meals. Consumer eating habits in and out of the home are changing rapidly as demand increases for healthier options that match specific dietary requirements. This growth in menu personalisation is putting huge pressure on restaurants, cafes and other food retailers. These providers have historically relied on identically mass produced meals to maintain their profit margins. By using robotics and machine learning, Karakuri’s systems provide localised micro-manufacturing within an existing restaurant, retail or commercial kitchen. Our systems prepare personalised meals onsite in real time to the exact requirements of each customer. At the same time, our technology aims to minimise food waste, packaging and distribution costs and all of the associated environmental impact."